Skip to content
Search

Latest Stories

RPS writes to GPhC over assessment technical faults

The General Pharmaceutical Council (GPhC) has confirmed that in its recently conducted registration assessment, three trainees could not complete the test due to technical glitches.

In response to the technical fault, the Royal Pharmaceutical Society (RPS) has written a letter to the GPhC, expressing its concerns about the issue and seeking a fair and timely resolution.


GPhC said three trainees in Redditch experienced technical difficulties during the break of the recent assessment which couldn’t be resolved by Pearson Vue support, and thus failed to complete paper two of the exam.

RPS stated in the letter that there is an apparent lack any adequate contingency plan for IT failure of this type.

GPhC have also stated that the trainees will not be able to resit the assessment until November.

RPS President Claire Anderson said this will lead to significant wellbeing implications on the trainees, therefore a paper should be available for the affected trainees before that time.

Anderson wrote in the letter: “Given the devastating impact for those trainees who will be unable to work as pharmacists for three months through no fault of their own, I urge you to develop a fairer solution (such as a sitting as soon as possible, only for the paper for which there were problems), alongside any appropriate compensation.”

RPS is also seeking ‘contingency planning’ around future risks, as GPhC have confirmed the assessment will be digital for the next three years.

“It is now incumbent upon you (GPhC) as the regulator to take responsibility for this oversight and improve contingency planning to prevent such serious implications for trainees. I urge you to open up the GPhC risk assessment and mitigation plans to public scrutiny so that the profession can be assured this type of thing will not happen again,” Anderson added.

GPhC earlier stated that 2,915 candidates sat the registration assessment on 27, 28 and 29 July, with the vast majority of these completing the sitting in Pearson test centres across the UK, and with 34 candidates sitting remotely in the UK and overseas using Pearson’s OnVUE system.

This was the second registration assessment sitting that took place online and the three sittings were delivered successfully for the vast majority of candidates.

Several candidates, who sat remotely, were unable to sit the online registration assessment due to internet connection issues.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less